People: Omeros Corp (OMER.OQ)
18 Apr 2019
Dr. Justin McCue Ph.D. is Vice President of Chemistry, Manufacturing and Controls of the company. As vice president of CMC, Dr. McCue oversees for Omeros all development, manufacturing, and supply of both biological and small-molecule drugs. Dr. McCue joins Omeros from Celgene where he headed the development of CAR T-cell and T-cell receptor (TCR) therapy manufacturing processes. Prior to Celgene, he led Biogen's CMC activities for the multi-billion-dollar drugs AVONEX ® and PLEGRIDY ® , approved for the treatment of multiple sclerosis in more than 90 countries. He began his career in the biopharmaceutical division at Millipore. Dr. McCue earned his Ph.D. and completed a post-doctoral fellowship in chemical engineering at Massachusetts Institute of Technology (M.I.T.) after receiving a degree in chemical engineering at University of California at Berkeley.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|